ipidacrine

Ukraine

Drugs containing this active substance

  • COGNIFEN®

    The drug is used to treat nervous system disorders accompanied by impairment of memory, attention, speech, and intellectual functions. It is prescribed for the consequences of strokes, traumatic brain injuries, cerebral atherosclerosis, age-related brain changes, as well as to improve performance and concentration during stress.

    Form: capsules, hard

    Active substance Dosage
    phenibut 300 mg
    ipidacrine 5 mg

    ATC: N06BX

    Manufacturer: JSC "Olyinpharm"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., neuropathy, myasthenia) and diseases of the central nervous system (bulbar paralysis, recovery after CNS damage accompanied by motor disorders).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 5 mg/ml

    ATC: N07AA*

    Manufacturer: PJSC "Lekhim-Kharkiv"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., myasthenia, neuropathies) and diseases of the central nervous system (bulbar paralysis, recovery after CNS damage accompanied by motor disorders).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 15 mg/ml

    ATC: N07AA*

    Manufacturer: PJSC "Lekhim-Kharkiv"

  • The drug is prescribed for the treatment of diseases of the peripheral nervous system (e.g., neuropathy, myasthenia) and the central nervous system (bulbar paralysis, paresis, as well as for recovery after organic lesions of the CNS accompanied by movement disorders).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 15 mg/ml

    ATC: N07AA

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., neuritis, polyneuropathy), myasthenia gravis, bulbar paralysis, as well as memory disorders (Alzheimer's disease), multiple sclerosis, and intestinal atony.

    Form: tablets

    Active substance Dosage
    ipidacrine 20 mg

    ATC: N07AA

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., neuropathy, myasthenia) and the central nervous system (bulbar paralysis, recovery after CNS damage accompanied by motor disorders).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 5 mg/ml

    ATC: N07AA

    Manufacturer: LLC "Corporation "Zdorovya"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., neuritis, polyneuropathy), myasthenia gravis, bulbar paralysis, multiple sclerosis, as well as memory disorders (Alzheimer's disease) and intellectual development delay in children. It is also used for intestinal atony.

    Form: tablets

    Active substance Dosage
    ipidacrine 20 mg

    ATC: N07AA

    Manufacturer: JSC "Grendix"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., myasthenia, neuropathies), as well as diseases of the central nervous system, such as bulbar paralysis and paresis, or during the recovery period after CNS damage.

    Form: solution for injection

    Active substance Dosage
    ipidacrine 5 mg/ml

    ATC: N07AA

    Manufacturer: JSC "Gryndex" (manufacturer responsible for batch release, including batch control/testing)

  • The drug is used to treat diseases of the peripheral nervous system (e.g., myasthenia, neuropathies) and diseases of the central nervous system (bulbar paralysis, recovery after CNS damage). It also helps to improve memory and slow the progression of dementia.

    Form: solution for injection

    Active substance Dosage
    ipidacrine 15 mg/ml

    ATC: N07AA

    Manufacturer: JSC "Gryndeks" (manufacturer responsible for batch release, including batch control/testing)

  • The drug is used to treat diseases of the peripheral nervous system (e.g., neuropathy, myasthenia), as well as diseases of the central nervous system, such as bulbar paralysis, and for recovery after organic lesions of the nervous system.

    Form: solution for injection

    Active substance Dosage
    ipidacrine 15 mg/ml

    ATC: N07AA

    Manufacturer: PJSC "Halychpharm"

  • The drug is used for diseases of the peripheral nervous system (neuritis, polyneuropathies), myasthenia gravis, bulbar paralysis, memory disorders (e.g., Alzheimer's disease), multiple sclerosis, as well as intestinal atony.

    Form: tablets

    Active substance Dosage
    ipidacrine 20 mg

    ATC: N07AA

    Manufacturer: PJSC "Kyivmedpreparat"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., mono- and polyneuropathy, myasthenia) and the central nervous system (bulbar paralysis, recovery after CNS damage accompanied by motor disorders).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 5 mg/ml

    ATC: N07AA

    Manufacturer: JSC "Olfa" (Marketing Authorization Holder)

  • The drug is used to treat diseases of the peripheral nervous system (e.g., mono- and polyneuropathy, myasthenia) and diseases of the central nervous system (bulbar paralysis, paresis, as well as recovery after CNS damage accompanied by motor disorders).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 15 mg/ml

    ATC: N07AA

    Manufacturer: JSC "Olfa" (Marketing Authorization Holder)

  • The drug is used for diseases of the peripheral nervous system (neuritis, polyneuropathies), myasthenia, bulbar paralysis, memory disorders (e.g., Alzheimer's disease), multiple sclerosis, and intestinal atony. It also aids in recovery after central nervous system damage.

    Form: tablets

    Active substance Dosage
    ipidacrine 20 mg

    ATC: N07AA

    Manufacturer: JSC "Olfa"

  • The drug is used to treat diseases of the peripheral nervous system (e.g., neuropathy, myasthenia) and diseases of the central nervous system (bulbar paralysis, paresis, recovery after CNS damage).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 5 mg/ml

    ATC: N07AA

    Manufacturer: PJSC "Lekhim - Kharkiv" (responsible for manufacturing, primary and secondary packaging, control and testing of batch, excluding batch release)

  • The drug is used for the treatment of peripheral nervous system diseases (e.g., neuropathy, myasthenia) and central nervous system diseases (bulbar paralysis, paresis, as well as the recovery period after CNS damage accompanied by motor disorders).

    Form: solution for injection

    Active substance Dosage
    ipidacrine 15 mg/ml

    ATC: N07AA

    Manufacturer: PJSC "Lekhim - Kharkiv" (responsible for manufacturing, primary and secondary packaging, control and testing of batch, excluding batch release)